[Form 4] Ardent Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Ardent Health, Inc. (ARDT) Form 4: Chief Financial Officer Alfred Lumsdaine reported a transaction on 09/25/2025 in which 3,389 shares of the issuer's common stock were disposed of at a price of $13.19 per share. The filing states the shares were withheld to pay taxes upon vesting of restricted stock units. After the reported disposition, the reporting person beneficially owns 211,147 shares, held directly. The form was signed by an attorney-in-fact on 09/30/2025.

Positive

• Reporting person retains direct beneficial ownership of 211,147 shares after the transaction
• Disposition is explicitly described as tax withholding for vested RSUs, indicating an administrative purpose rather than a discretionary open-market sale

Negative

• 3,389 shares were disposed of on 09/25/2025
• Price per share reported is $13.19, reflecting the closing price on the transaction date

Insights

Securities Analyst

TL;DR: The company's CFO sold a small parcel of shares via tax-withholding on vested RSUs, retaining a substantial direct stake of 211,147 shares.

The transaction reported is a routine disposition tied to tax withholding for vested restricted stock units rather than an open-market sale for cash generation. The disposed amount, 3,389 shares at $13.19, represents the mechanism to satisfy tax obligations on equity compensation. The post-transaction direct beneficial ownership of 211,147 shares is explicitly stated, indicating continued alignment with shareholder interests. No derivative transactions or additional changes in ownership form are reported.

Corporate Governance Expert

TL;DR: This Form 4 documents a standard RSU tax-withholding disposition by an officer, with no governance red flags disclosed.

The filing specifies the nature of the disposition as tax withholding upon vesting of restricted stock units, which is a common administrative event. The form identifies the reporting person as CFO and shows the filing was executed by an attorney-in-fact. There are no amendments, no derivative security activity, and no indication of insider trading outside the stated withholding. The information is limited to the single non-derivative disposition and resulting beneficial ownership count.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

LUMSDAINE ALFRED

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/25/2025		F		3,389(1)	D	$13.19(2)	211,147	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

2. Represents the closing price of the common stock of the Issuer on September 25, 2025.

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	09/30/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ARDT CFO Alfred Lumsdaine report on Form 4?

He reported a disposition of 3,389 shares on 09/25/2025, withheld to pay taxes on vested restricted stock units.

At what price were the ARDT shares reported disposed of?

The filing lists the price as $13.19, the closing price of ARDT common stock on 09/25/2025.

How many ARDT shares does the reporting person beneficially own after the transaction?

The reporting person beneficially owns 211,147 shares following the reported disposition.

Was the Form 4 filed jointly or by one reporting person?

The form indicates it was filed by one reporting person.

Who signed the Form 4 and when?

The form was signed by Stephen C. Petrovich, Attorney-in-Fact on 09/30/2025.